Trophoblastic disease

被引：59

作者：

Ngan, Hextan Y. S. ^{[1
]}

Kohorn, Ernest I. ^{[2
]}

Cole, Laurence A. ^{[3
,4
]}

Kurman, Robert J. ^{[5
]}

Kim, Seung J. ^{[6
]}

Lurain, John R. ^{[7
]}

Seckl, Michael J. ^{[8
]}

Sasaki, Shigeru ^{[9
]}

Soper, John T. ^{[10
]}

机构：

[1] Univ Hong Kong, Queen Mary Hosp, Dept Obstet & Gynecol, Hong Kong, Hong Kong, Peoples R China

[2] Yale Univ, Sch Med, Dept Gynecol & Obstet, New Haven, CT USA

[3] Univ New Mexico, Hlth Sci Ctr, USA hCG Reference Serv, Dept Obstet & Gynecol, Albuquerque, NM 87131 USA

[4] Univ New Mexico, Hlth Sci Ctr, Dagger Dept Biochem & Mol Biol, Albuquerque, NM 87131 USA

[5] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA

[6] Bundang CHA Gen Hosp, Gynecol Canc Ctr, Songnam, South Korea

[7] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Brewer Trophoblast Dis Ctr, Chicago, IL 60611 USA

[8] Charing Cross Hosp, Dept Med Oncol, London W6 8RF, England

[9] Tama Nagayama Hosp, Dept Obstet & Gynecol, Tokyo, Japan

[10] Duke Univ, Med Ctr, Div Gynecol Oncol, Durham, NC USA

来源：

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS | 2012年 / 119卷

关键词：

GYNECOLOGIC-ONCOLOGY-GROUP; PHASE-II TRIAL; HYDATIDIFORM MOLE; RISK; NEOPLASIA; CHEMOTHERAPY; METHOTREXATE; TUMORS; CLASSIFICATION; EPIDEMIOLOGY;

D O I：

10.1016/S0020-7292(12)60026-5

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

[No abstract available]

引用

页码：S130 / S136

页数：7

共 25 条

[1] First line chemotherapy in low risk gestational trophoblastic neoplasia [J].

Alazzam, Mo'iad ;

Tidy, John ;

Hancock, Barry W. ;

Osborne, Raymond .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (01)

[2]

BAGSHAWE KD, 1976, CANCER-AM CANCER SOC, V38, P1373, DOI 10.1002/1097-0142(197609)38:3<1373::AID-CNCR2820380342>3.0.CO

[3]

2-E

[4] EMA/CO REGIMEN IN HIGH-RISK GESTATIONAL TROPHOBLASTIC TUMOR (GTT) [J].

BOLIS, G ;

BONAZZI, C ;

LANDONI, F ;

MANGILI, G ;

VERGADORO, F ;

ZANABONI, F ;

MANGIONI, C .

GYNECOLOGIC ONCOLOGY, 1988, 31 (03) :439-444

[5] EMA/CO for high-risk gestational trophoblastic tumors: Results from a cohort of 272 patients [J].

Bower, M ;

Newlands, ES ;

Holden, L ;

Short, D ;

Brock, C ;

Rustin, GJS ;

Begent, RHJ ;

Bagshawe, KD .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (07) :2636-2643

[6]

BOWER M, 1997, J CLIN ONCOL, V15, P3168

[7] Phase II trial of pulse dactinomycin as salvage therapy for failed low-risk gestational trophoblastic neoplasia - A Gynecologic Oncology Group study [J].

Covens, Allan ;

Filiaci, Virginia L. ;

Burger, Robert A. ;

Osborne, Raymond ;

Chen, M. Dwight .

CANCER, 2006, 107 (06) :1280-1286

[8] Gestatioinal trophoblastic disease [J].

Garner, Elizabeth I. O. ;

Goldstein, Donald P. ;

Feltmate, Colleen M. ;

Berkowitz, Ross S. .

CLINICAL OBSTETRICS AND GYNECOLOGY, 2007, 50 (01) :112-122

[9] TREATMENT OF METASTATIC TROPHOBLASTIC DISEASE - GOOD AND POOR PROGNOSIS [J].

HAMMOND, CB ;

BORCHERT, LG ;

TYREY, L ;

CREASMAN, WT ;

PARKER, RT .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1973, 115 (04) :451-457

[10] RAPID ESCALATION OF WEEKLY INTRAMUSCULAR METHOTREXATE FOR NONMETASTATIC GESTATIONAL TROPHOBLASTIC DISEASE - A GYNECOLOGIC ONCOLOGY GROUP-STUDY [J].

HOMESLEY, HD ;

BLESSING, JA ;

SCHLAERTH, J ;

RETTENMAIER, M ;

MAJOR, FJ .

GYNECOLOGIC ONCOLOGY, 1990, 39 (03) :305-308

← 1 2 3 →